Effects of the Low-level Laser Therapy (LLLT) on Muscle Strength (MS) of the Patients With Kidneys Failure (KF)

NCT ID: NCT02586376

Last Updated: 2016-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The low-level laser therapy (LLLT) has been used in many inflammatory disorders. More recently the LLLT was associated with an improvement in the muscle strength and endurance. But, these effects were described only in health or athletic individuals. In this randomized and controlled clinical trails, the investigators will study the effects of LLLT on muscle strength of the patients with kidneys failure on long time hemodialysis treatment. Additionally, investigators will explore three different intensities up the muscle strength.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be conducing in a large hospital that is reference in kidneys disorders treatments. 16 patients will be randomized for placebo, 4J, 6J, or 8J low-level laser therapy (LLLT). The maximal voluntary contraction (MVC) will be test by handgrip test before and after de LLLT. One-week interval between the LLLT will gave to reduce the influence between the treatments. Moreover the endurance test will be use to evaluate the muscle oxidation impact of the LLLT.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

0J LLLT

The intervention will be made with the machine off.

Group Type SHAM_COMPARATOR

0J LLLT

Intervention Type DEVICE

Sham Low-Level Laser Therapy (Sham LLLT): perform with the machine off.

4J LLLT

The Laser radiation will be made with 4J by spot.

Group Type EXPERIMENTAL

4J LLLT

Intervention Type DEVICE

4J Low-Level Laser Therapy (4J LLLT) irradiation will be perform with 4J.

6J LLLT

The Laser radiation will be made with 6J by spot.

Group Type EXPERIMENTAL

6J LLLT

Intervention Type DEVICE

6J Low-Level Laser Therapy (6J LLLT) irradiation will be perform with 6J.

8J LLLT

The Laser radiation will be made with 8J by spot.

Group Type EXPERIMENTAL

8J LLLT

Intervention Type DEVICE

8J Low-Level Laser Therapy (8J LLLT) irradiation will be perform with 8J.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

0J LLLT

Sham Low-Level Laser Therapy (Sham LLLT): perform with the machine off.

Intervention Type DEVICE

4J LLLT

4J Low-Level Laser Therapy (4J LLLT) irradiation will be perform with 4J.

Intervention Type DEVICE

6J LLLT

6J Low-Level Laser Therapy (6J LLLT) irradiation will be perform with 6J.

Intervention Type DEVICE

8J LLLT

8J Low-Level Laser Therapy (8J LLLT) irradiation will be perform with 8J.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sham LLLT 4J 6J 8J

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* chronic kidney failure,
* long time hemodialysis treatment (\>18 months)

Exclusion Criteria

* any health disturbance that can reduces the handgrip test performance beyond to the produced by the chronic kidney failure.
Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Federal University of Health Science of Porto Alegre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fabrício Edler Macagnan

Clinical Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fabrício E. Macagnan, PhD

Role: PRINCIPAL_INVESTIGATOR

Universidade Federal de Ciências da Saúde

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fabrício Edler Macagnan

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LLLT-RENAIS-2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Whole Body Vibration in Kidney Disease
NCT02413073 COMPLETED PHASE4